Search

Your search keyword '"Jawad, Maha Saada"' showing total 18 results
Start Over Author "Jawad, Maha Saada"
18 results on '"Jawad, Maha Saada"'

5. Analysis of Resident and Faculty Assessment Methods Used by United States Radiation Oncology Residency Programs

Author

Rajeev-Kumar, Greeshma, primary, Manjunath, Rajashri, additional, Tendulkar, Rahul, additional, Corbin, Kimberly, additional, Jagsi, Reshma, additional, Marwaha, Gaurav, additional, Johung, Kimberly, additional, Evans, Suzanne, additional, Jawad, Maha Saada, additional, Komarnicky-Kocher, Lydia, additional, Shinohara, Eric, additional, Yeung, Anamaria R., additional, Buckstein, Michael, additional, Das, Prajnan, additional, Harkenrider, Matthew, additional, Golden, Daniel W., additional, and Hasan, Yasmin, additional

Published
2021
Full Text
View/download PDF

8. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation

Author

Jawad, Maha Saada, Fahim, Daniel K, Gerszten, Peter C, Flickinger, John C, Sahgal, Arjun, Grills, Inga S, Sheehan, Jason, Kersh, Ronald, Shin, John, Oh, Kevin, Mantel, Frederick, Guckenberger, Matthias, University of Zurich, and Guckenberger, Matthias

Subjects
2728 Neurology (clinical), 2808 Neurology, 610 Medicine & health, 10044 Clinic for Radiation Oncology, 2746 Surgery
Published
2016

9. Dosimetric evaluation of target coverage as a predictor of local failure following stereotactic body radiation therapy for spinal tumors†

Author

Jawad, Maha Saada, Zhou, Jun, Harb, Joe G., Wilkinson, J. Ben, Prausa, Shannon K., Wloch, Jennifer, Krauss, Daniel J., Fahim, Daniel, Yan, Di, and Grills, Inga S.

Subjects
Clinical Investigation
Abstract

To perform a dosimetric analysis of target coverage and determine parameters predictive for local failure (LF) in patients undergoing spinal stereotactic body radiation therapy (sSBRT).Materials and Methods: Sixty-seven spinal tumors in 59 patients were treated with image-guided linac-based sSBRT from 2008-2012. Median prescription dose was 18Gy (8-35) delivered in 1-5 fractions (87% single-fraction). Prescription dose was targeted to cover ≥ 80% of PTV within spinal cord (SC) dose constraints (9/11Gy to 0.1cc SC/SC+2mm). Twelve tumors had local failure (LF, median time-to-failure 3.7 months) and were compared to 14 tumors with1-year follow-up and local control (LC). Univariate and multivariate analyses were performed to determine parameters predictive of LF.Median follow-up was 7.4 months and 24.7 months for LF and LC, respectively. Post-SBRT, 42% of LF patients had neurological symptoms due to tumor progression. No patients developed post-SBRT myelopathy. Pre-treatment PTV volumes were not statistically different (median/mean/range 61.8/74.5/19.9-206.4cc for LF vs 39.4/47.1/10.3-119.7cc for LC; p=0.13). LF tumors had larger volumes receiving80% of prescription dose (5.2cc vs 1.9cc, p=0.02) and larger overlap volume between GTV/SC within 2 and 3mm (p=0.01/p=0.007). LF tumors had lower GTV minimum dose (5.6 vs 8.5Gy, p=0.001) and smaller GTV to SC distance (0.06 vs 0.19mm, p=0.049). Maximum SC doses were not statistically different (6.4Gy LC vs 9.2Gy LF, p=0.33). GTV minimum dose was predictive of LF, with a trend for overlapping GTV/SC volume within 2mm.Minimum GTV dose, PTV volume receiving80% prescription dose, smaller GTV-SC distance, and large overlapping volume of PTV/SC are predictive of LF after SBRT. Given the absence of SC toxicity but neurological progression upon LF, less conservative SC constraints should be considered.

Published
2015

10. Vertebral compression fractures after stereotactic body radiation therapy: a large, multi-institutional, multinational evaluation

Author

Jawad, Maha Saada, primary, Fahim, Daniel K., additional, Gerszten, Peter C., additional, Flickinger, John C., additional, Sahgal, Arjun, additional, Grills, Inga S., additional, Sheehan, Jason, additional, Kersh, Ronald, additional, Shin, John, additional, Oh, Kevin, additional, Mantel, Frederick, additional, and Guckenberger, Matthias, additional

Published
2016
Full Text
View/download PDF

14. Dosimetric predictors of toxicity and cosmesis in women treated with hypofractionated whole-breast irradiation.

Author

Dilworth, Joshua T., primary, Hymas, Richard Val, additional, Jawad, Maha Saada, additional, Mangona, Victor S., additional, Zamdborg, Leonid, additional, Wobb, Jessica, additional, Pietron, Arielle, additional, Wallace, Michelle, additional, Chen, Peter Y., additional, Grills, Inga S., additional, and Brabbins, Donald S., additional

Published
2014
Full Text
View/download PDF

18. Dosimetric evaluation of target coverage as a predictor of local failure following stereotactic body radiation therapy for spinal tumors.

Author

Jawad MS, Zhou J, Harb JG, Wilkinson JB, Prausa SK, Wloch J, Krauss DJ, Fahim D, Yan D, and Grills IS

Abstract

Purpose: To perform a dosimetric analysis of target coverage and determine parameters predictive for local failure (LF) in patients undergoing spinal stereotactic body radiation therapy (sSBRT).Materials and Methods: Sixty-seven spinal tumors in 59 patients were treated with image-guided linac-based sSBRT from 2008-2012. Median prescription dose was 18Gy (8-35) delivered in 1-5 fractions (87% single-fraction). Prescription dose was targeted to cover ≥ 80% of PTV within spinal cord (SC) dose constraints (9/11Gy to 0.1cc SC/SC+2mm). Twelve tumors had local failure (LF, median time-to-failure 3.7 months) and were compared to 14 tumors with >1-year follow-up and local control (LC). Univariate and multivariate analyses were performed to determine parameters predictive of LF., Results: Median follow-up was 7.4 months and 24.7 months for LF and LC, respectively. Post-SBRT, 42% of LF patients had neurological symptoms due to tumor progression. No patients developed post-SBRT myelopathy. Pre-treatment PTV volumes were not statistically different (median/mean/range 61.8/74.5/19.9-206.4cc for LF vs 39.4/47.1/10.3-119.7cc for LC; p=0.13). LF tumors had larger volumes receiving <80% of prescription dose (5.2cc vs 1.9cc, p=0.02) and larger overlap volume between GTV/SC within 2 and 3mm (p=0.01/p=0.007). LF tumors had lower GTV minimum dose (5.6 vs 8.5Gy, p=0.001) and smaller GTV to SC distance (0.06 vs 0.19mm, p=0.049). Maximum SC doses were not statistically different (6.4Gy LC vs 9.2Gy LF, p=0.33). GTV minimum dose was predictive of LF, with a trend for overlapping GTV/SC volume within 2mm., Conclusions: Minimum GTV dose, PTV volume receiving <80% prescription dose, smaller GTV-SC distance, and large overlapping volume of PTV/SC are predictive of LF after SBRT. Given the absence of SC toxicity but neurological progression upon LF, less conservative SC constraints should be considered.

Published
2015

Catalog

Books, media, physical & digital resources
See catalog results